| PASylation of Murine Leptin Leads to Extended Plasma Half-Life and Enhanced in Vivo Efficacy V Morath, F Bolze, M Schlapschy, S Schneider, F Sedlmayer, K Seyfarth, ... Molecular pharmaceutics 12 (5), 1431-1442, 2015 | 81 | 2015 |
| A platform for discovery of functional cell-penetrating peptides for efficient multi-cargo intracellular delivery K Hoffmann, N Milech, SM Juraja, PT Cunningham, SR Stone, ... Scientific reports 8 (1), 12538, 2018 | 63 | 2018 |
| Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA) C Barinka, J Ptacek, A Richter, Z Novakova, V Morath, A Skerra Protein Engineering, Design and Selection 29 (3), 105-115, 2016 | 46 | 2016 |
| The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma M Heider, R Eichner, J Stroh, V Morath, A Kuisl, J Zecha, J Lawatscheck, ... Molecular cell 81 (6), 1170-1186. e10, 2021 | 45 | 2021 |
| Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy S Hagen, T Baumann, HJ Wagner, V Morath, B Kaufmann, A Fischer, ... Scientific reports 4 (1), 3759, 2014 | 41 | 2014 |
| Long-Acting PASylated Leptin Ameliorates Obesity by Promoting Satiety and Preventing Hypometabolism in Leptin-Deficient Lepob/ob Mice F Bolze, V Morath, A Bast, N Rink, M Schlapschy, S Mocek, A Skerra, ... Endocrinology 157 (1), 233-244, 2016 | 36 | 2016 |
| First In-Human Medical Imaging with a PASylated 89Zr-Labeled Anti-HER2 Fab-Fragment in a Patient with Metastatic Breast Cancer A Richter, K Knorr, M Schlapschy, S Robu, V Morath, C Mendler, HY Yen, ... Nuclear Medicine and Molecular Imaging 54, 114-119, 2020 | 30 | 2020 |
| Novel monoclonal antibodies recognizing human prostate‐specific membrane antigen (PSMA) as research and theranostic tools Z Nováková, CA Foss, BT Copeland, V Morath, P Baranová, B Havlínová, ... The Prostate 77 (7), 749-764, 2017 | 30 | 2017 |
| PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice Y Xia, M Schlapschy, V Morath, N Roeder, EI Vogt, D Stadler, X Cheng, ... Antiviral Research 161, 134-143, 2019 | 29 | 2019 |
| Development of a high affinity Anticalin® directed against human CD98hc for theranostic applications FC Deuschle, V Morath, A Schiefner, C Brandt, S Ballke, S Reder, ... Theranostics 10 (5), 2172, 2020 | 28 | 2020 |
| The in vitro PIG-A gene mutation assay: glycosylphosphatidylinositol (GPI)-related genotype-to-phenotype relationship in TK6 cells CT Krüger, BM Fischer, O Armant, V Morath, U Strähle, A Hartwig Archives of toxicology 90, 1729-1736, 2016 | 28 | 2016 |
| Treatment of diet-induced lipodystrophic C57BL/6J mice with long-acting PASylated leptin normalises insulin sensitivity and hepatic steatosis by promoting lipid utilisation F Bolze, A Bast, S Mocek, V Morath, D Yuan, N Rink, M Schlapschy, ... Diabetologia 59, 2005-2012, 2016 | 16 | 2016 |
| The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy C Kitzberger, R Spellerberg, V Morath, N Schwenk, KA Schmohl, C Schug, ... EJNMMI research 12 (1), 25, 2022 | 14 | 2022 |
| Is hypoxia a factor influencing PSMA-directed radioligand therapy?—An in silico study on the role of chronic hypoxia in prostate cancer G Birindelli, M Drobnjakovic, V Morath, K Steiger, C D’Alessandria, ... Cancers 13 (14), 3429, 2021 | 11 | 2021 |
| Design and Characterization of a Modular Membrane Protein Anchor to Functionalize the Moss Physcomitrella patens with Extracellular Catalytic and/or Binding … V Morath, DJJ Truong, F Albrecht, I Polte, RA Ciccone, LF Funke, ... ACS synthetic biology 3 (12), 990-994, 2014 | 7 | 2014 |
| Synthetische Biologie: Entwicklung einer neuen Ingenieurbiologie?; Themenband der Interdisziplinären Arbeitsgruppe Gentechnologiebericht K Köchy, J Diekämper, A Hümpel, H Fangerau, N Budisa, N Hotz, ... | 7 | 2012 |
| A theranostic approach for CAR-T cell therapy WA Weber, Z Varasteh, K Fritschle, V Morath Clinical Cancer Research 28 (24), 5241-5243, 2022 | 5 | 2022 |
| In silico study on radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapy G Birindelli, M Drobnjakovic, V Morath, K Steiger, C D’Alessandria, ... 2021 43rd Annual International Conference of the IEEE Engineering in …, 2021 | 5 | 2021 |
| Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice C Kitzberger, K Shehzad, V Morath, R Spellerberg, J Ranke, K Steiger, ... Molecular Therapy-Oncolytics 30, 238-253, 2023 | 4 | 2023 |
| Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma V Morath, M Heider, M Mittelhäuser, H Rolbieski, J Stroh, J Calais, ... EJNMMI research 12 (1), 4, 2022 | 4 | 2022 |
